Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity.
Headquartered in Denmark, Novo Nordisk employs approximately 42,100 people in 79 countries, and markets its products in more than 170 countries.
http://www.novonordisk.co.uk/
LSX is an influential community of senior life science decision makers.
We connect senior biotech, medtech & healthtech executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses.
© 2020 All Rights Reserved By LSX Ltd | Privacy Policy
